Company
Headquarters: Liuzhou, China
Employees: 4,706
CN¥7.12 Billion
CNY as of July 1, 2024
US$979.7 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $75.67 B |
| Cencora, Inc. | $43.82 B |
| Cardinal Health, Inc. | $23.31 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $8.79 B |
| Sinopharm Group Co. Ltd | $8.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Guangxi Liuzhou Pharmaceutical Co., Ltd. engages in the distribution and retail of pharmaceutical products in China. The company was founded in 1981 and is based in Liuzhou, China. Guangxi Liuzhou Pharmaceutical Co., Ltd. is a subsidiary of Liuzhou Liangmianzhen Co., Ltd.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Guangxi Liuzhou Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603368 wb_incandescent